GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Downstream of Akt in the tumor vessel

$452,831
William C Aird · Beth Israel Deaconess Medical Center · R01 · FY2012 · CA

Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance

$452,797
Keith Syson Chan · Methodist Hospital Research Institute · R01 · FY2025 · CA

Developmental studies to inform clinical stratification and targeting of SHH MB

$452,783
Alexandra L. Joyner · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

Context-specific functions of genes and cells

$452,762
Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

NextGen - CHOP

$452,749
John M Maris · Children'S Hosp Of Philadelphia · OT2 · FY2025 · CA

Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes

$452,675
Barbara Savoldo · Baylor College Of Medicine · R01 · FY2014 · HL

Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis

$452,653
Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2022 · CA

Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis

$452,653
Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2024 · CA

Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis

$452,653
Enrique A Mesri · University Of Miami School Of Medicine · R01 · FY2021 · CA

Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis

$452,653
Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2023 · CA

Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis

$452,652
Enrique A Mesri · University Of Miami School Of Medicine · R01 · FY2020 · CA

UCSC-Buck Specialized Genomic Data Analysis Center for the Genomic Data Analysis Network

$452,649
Joshua Michael Stuart · University Of California Santa Cruz · U24 · FY2017 · CA

Pacritinib in rel/refr T-cell lymphomas

$452,633
Ryan A Wilcox · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

Reversing immune evasion and enhancing immune detection with topical resiquimod

$452,618
Rachael Ann Clark · Brigham And Women'S Hospital · R01 · FY2020 · AR

Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy

$452,588
Taha Merghoub · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Modeling and targeting intrinsic and extrinsic features of Myc-driven Osteosarcoma

$452,549
Jason Yustein · Emory University · R01 · FY2025 · CA

Targeting Tregs in the solid tumor microenvironment by modulating metabolite signaling

$452,544
Sinã‰ad Kinsella · Fred Hutchinson Cancer Center · R21 · FY2024 · CA

Targeting CD5 on Tumor-associated T and B cells to improve PD-1 blockade in Breast Cancer

$452,540
Chunyan Zhang · Beckman Research Institute/City Of Hope · R21 · FY2020 · CA

Bispecific antibodies in multiple myeloma: understanding therapy resistance through imaging

$452,540
Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R21 · FY2025 · CA

Rapid Motion-Robust and Easy-to-Use Dynamic Contrast-Enhanced MRI for Liver Perfusion Quantification

$452,460
Li Feng · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · EB

Targeting Ischemia-Induced Dependencies on the Metabolic Stress Response in Hepatocellular Carcinoma Through Image-Guided, Locoregional Therapy

$452,450
Terence P Gade · University Of Pennsylvania · R01 · FY2020 · CA

Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma

$452,423
Shumei Song · Coriell Institute For Medical Research · R01 · FY2023 · CA

Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy

$452,330
Matthew J Lazzara · University Of Virginia · U01 · FY2023 · CA

Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy

$452,330
Matthew J Lazzara · University Of Virginia · U01 · FY2022 · CA

Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment

$452,287
Shihui Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA